Cellulite Severity Photonumeric Scales for Consistent Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing and treating cellulite lack accuracy and consistency, with existing scales showing significant variability in physician and patient evaluations, and there is a need for effective therapies that can safely and reliably improve the aesthetic outcome of cellulite.
Innovation Solution
Development of validated Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) and Patient Reported Photonumeric Cellulite Severity Scale (PR-PCSS) to quantify cellulite severity, combined with the use of collagenase derived from Clostridium histolyticum for treatment, allowing for objective assessment and improvement evaluation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional assessment scales are used for cellulite severity, then assessment can be performed, but significant variability exists in physician and patient evaluations reducing reliability
Solution Approach 1:
The assessment scale is segmented into specific anatomical regions (gluteal region, thigh, abdomen) with standardized photography protocols for each region. This segmentation allows for consistent, region-specific assessment that reduces variability between evaluators while maintaining measurement precision through detailed, localized evaluation criteria.
Solution Approach 2:
Standardized reference photographs are created as templates representing different cellulite severity levels. Evaluators compare patient photographs against these standardized reference images, ensuring consistent assessment across different physicians and patients. This copying approach eliminates subjective interpretation variability while preserving accurate severity classification.
2Adaptability or versatility
If multiple therapeutic modalities are used for cellulite treatment, then various approaches are available, but scientific evidence of benefit is limited and anecdotal
Solution Approach 1:
The standardized assessment scale provides quantitative baseline measurements and follow-up evaluations that offer objective feedback on treatment effectiveness. This feedback mechanism transforms anecdotal observations into measurable data, allowing verification of treatment benefits across different modalities while maintaining treatment versatility.
Solution Approach 2:
The invention introduces objective measurement parameters (photograph-based severity scoring) that can quantify treatment outcomes. By changing from subjective anecdotal assessment to objective parameter-based evaluation, the reliability of treatment effectiveness evidence is improved while preserving multiple treatment option versatility.
3Ease of operation
If some historical treatments are applied for cellulite, then treatment can be provided, but increased risk for adverse effects is posed
Solution Approach 1:
Standardized baseline photography and assessment are performed before treatment to establish objective criteria for treatment selection and safety monitoring. This preliminary action allows for risk assessment and treatment planning that minimizes adverse effects while maintaining treatment availability through informed decision-making.
Solution Approach 2:
Objective measurement feedback from standardized photography and severity scoring enables continuous monitoring of treatment response and safety. This feedback system allows early detection of adverse effects and及时调整 of treatment parameters, maintaining ease of operation while reducing harmful factors through data-driven treatment optimization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scales provide high intra- and inter-rater reliability, enabling consistent evaluation of cellulite severity and treatment effectiveness, with collagenase treatment demonstrating significant improvements in cellulite appearance as measured by both clinician and patient scales.
Implementation Method 1
XIAFLEX (collagenase Clostridium histolyticum, or CCH, or EN3835) is a biologic approved in the U.S., EU, Canada, Australia and Japan for the treatment of adult Dupuytren's contracture (DC) patients with a palpable cord and in the U.S. and EU for the treatment of adult men with Peyronie's disease (PD) with a palpable plaque and penile curvature deformity of at least 30 degrees at the start of therapy.
Data Source
AI summary
The present disclosure relates to a method for rating the severity of cellulite on a thigh or buttock in a human subject by utilizing a photonumeric scale that provides reliable results from physician-to-physician and patient-to-patient.